This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmaceutical agents. Its structure, featuring a chiral center and a bromophenyl group, makes it valuable for the development of enantioselective drugs, particularly those targeting neurological and psychiatric disorders. It is often employed in the preparation of β-adrenergic receptor agonists, which are used to treat conditions like asthma and cardiovascular diseases. Additionally, its presence in research settings aids in the study of receptor-ligand interactions, contributing to the design of more effective and selective therapeutic molecules.